The following people constitute the Editorial Board of Academic Editors for PeerJ. These active academics are the Editors who seek peer reviewers, evaluate their responses, and make editorial decisions on each submission to the journal. Learn more about becoming an Editor.
Scientific advisor at the Institute of Biophysics, Biological Research Centre of the Hungarian Academy of Sciences in Szeged, Hungary. Head of the Biological barriers research group in the Molecular Neurobiology Unit.
Team leader Proteomics Center & Assistant Professor Erasmus University Medical Center Rotterdam
EUR Fellow, Erasmus University Medical Center
Postdoc, The Rockefeller University (Chait lab)
PhD, Utrecht University (Heck & Killian labs)
MSc (hons) Chemistry, Utrecht University
Assistant Professor of Medicine, Division of Pulmonary and Critical Care Medicine, UCLA School of Medicine.
CSIRO Fellow. Distinguished professor, University of technology, Sydney, Past Chairman of the Multinational Arabidopsis Genome Project. Past President of the Australian Society of Biochemistry and Molecular Biology, winner Prime Minister's prize for Science.
Dr José Derraik was born in Rio de Janeiro (Brazil), but moved to New Zealand in 1995. José has a very broad academic background, with a BSc and MSc in Ecology from the University of Otago (New Zealand), and a PhD in Public Health (University of Otago). His MSc examined invertebrate biodiversity in human-modified habitats. His PhD focused on vector ecology, more precisely on mosquitoes in New Zealand and how the threat of a mosquito-borne disease outbreak has been affected by ongoing anthropogenic environmental change. José then worked as a Senior Advisor for MAF Biosecurity NZ, where he provided expert advice to the NZ government on biosecurity threats to human health.
In 2008, José joined the Liggins Institute (University of Auckland) where he has been working on paediatric research, as well as on a number of clinical trials in adolescents and adults at risk of metabolic disease. His research focuses primarily on the long-term effects of early life events (such as preterm or post-term birth) in childhood. However, José has recently been appointed as an honorary research associate at Uppsala University in Sweden, where alongside his Swedish colleagues he has been examining also the long-term effects of early life events in adulthood.
Lastly, José is currently involved in a large multi-institutional project (A Better Start) in New Zealand, with a leading role in a number of studies aiming to predict, prevent, and mitigate childhood obesity in the country.
Professor and Chair of the Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Fred Wright Professor of Cancer Biology
Lecturer at University College London (UCL) on a joint appointment between the Department of Genetics, Evolution & Environment and the Department of Computer Science.
Professor of Medicine, Molecular Microbiology, Pathology & Immunology at Washington University School of Medicine (USA) and the Co-Director of the Midwest Regional Center for Excellence in Biodefense and Emerging Infectious Disease Research.
Jiajie Diao is a researcher in the Cancer Biology Department, College of Medicine.
He has an interest in Membrane Biophysics (Single-vesicle study of SNARE-mediated membrane fusion; Single-molecule analysis of protein conformational change in membrane environment;Membrane property change induced by protein) and Nanotechnology (Nanoparticle structures for biomedical detection).
Associate Research Professor in Bioinformatics at Florida Atlantic University. Research focus genomics of marine organisms, environmental microbiomes and machine learning to understand genome sequence. Wellcome Trust Centre for Molecular Parasitology, University of Glasgow Bioinformatics team for 7 years and lead the team for 4 of those. Also lead an experimental sequencing team in the Centre and has a bioinformatics research group. Originally, studied Biology at Imperial College London and moved into bioinformatics at NV Organon Pharmaceuticals in the Netherlands. Following this he had a research post at the MRC Functional Genetics Unit, University of Oxford where he stayed to do his genome informatics PhD. Has held research post-doctoral posts in London working in type-2 diabetes and cardiovascular disease at Imperial College, and cancer biology at the Institute of Cancer Research.
Burton F. Dickey is a Professor and Chair of the Department of Pulmonary Medicine at the University of Texas MD Anderson Cancer Center. He has studied vesicle traffic since fellowship training more than thirty years ago, and for the past seventeen years his principal focus has been airway mucin secretion. His laboratory uses a mouse genetic approach, knocking out or overexpressing genes in airway secretory cells to study their function. This approach also allows the use of these genetically modified mice in models of pathologic challenge. Together, this provides fundamental insight into the mechanism of mucin secretion and how its dysregulation contributes to pathophysiology. He has also contributed to related work on inducible epithelial resistance to infection, promotion of lung carcinogenesis by inflammation, and modulation of inflammation by β2-agonists. As a clinician, Dr. Dickey focuses on diseases of the airways to promote the transfer of knowledge between laboratory and clinic. He has founded two biotechnology companies, Pulmotect and Exotect, to develop therapeutics to treat respiratory infections and muco-obstructive lung diseases, respectively.